1. Home
  2. LEGN vs GGB Comparison

LEGN vs GGB Comparison

Compare LEGN & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • GGB
  • Stock Information
  • Founded
  • LEGN 2014
  • GGB 1901
  • Country
  • LEGN United States
  • GGB Brazil
  • Employees
  • LEGN N/A
  • GGB N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • GGB Steel/Iron Ore
  • Sector
  • LEGN Health Care
  • GGB Industrials
  • Exchange
  • LEGN Nasdaq
  • GGB Nasdaq
  • Market Cap
  • LEGN 5.4B
  • GGB 5.7B
  • IPO Year
  • LEGN 2020
  • GGB 1999
  • Fundamental
  • Price
  • LEGN $38.96
  • GGB $2.98
  • Analyst Decision
  • LEGN Strong Buy
  • GGB Strong Buy
  • Analyst Count
  • LEGN 12
  • GGB 1
  • Target Price
  • LEGN $73.91
  • GGB $3.80
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • GGB 14.8M
  • Earning Date
  • LEGN 08-08-2025
  • GGB 07-30-2025
  • Dividend Yield
  • LEGN N/A
  • GGB 3.45%
  • EPS Growth
  • LEGN N/A
  • GGB N/A
  • EPS
  • LEGN N/A
  • GGB 0.27
  • Revenue
  • LEGN $728,303,000.00
  • GGB $11,893,560,444.00
  • Revenue This Year
  • LEGN $65.49
  • GGB $7.47
  • Revenue Next Year
  • LEGN $53.76
  • GGB $6.01
  • P/E Ratio
  • LEGN N/A
  • GGB $10.42
  • Revenue Growth
  • LEGN 112.46
  • GGB 2.92
  • 52 Week Low
  • LEGN $27.34
  • GGB $2.27
  • 52 Week High
  • LEGN $60.87
  • GGB $3.62
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 66.26
  • GGB 51.71
  • Support Level
  • LEGN $34.64
  • GGB $3.03
  • Resistance Level
  • LEGN $39.88
  • GGB $3.14
  • Average True Range (ATR)
  • LEGN 1.46
  • GGB 0.07
  • MACD
  • LEGN 0.37
  • GGB -0.00
  • Stochastic Oscillator
  • LEGN 87.67
  • GGB 50.00

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.

Share on Social Networks: